Wednesday, November 11, 2020 7:28:14 AM
SALT LAKE CITY, Nov. 11, 2020 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that a recent Company whitepaper demonstrates that the CoPrimer™ platform technology can be used to identify the presence of SARS-CoV-2 in human saliva samples without first requiring RNA extraction of the sample, and can do so while providing low limits of detection.
The technical advance featured in the whitepaper, found here, was the result of a study into the compatibility of CoPrimer technology with detection of SARS-CoV-2 directly from raw saliva. Various CoPrimer assay configurations were used to consistently detect SARS-CoV-2 in minimally processed saliva in the whitepaper, which concludes that CoPrimers provide a robust platform for the development of such tests.
Dwight Egan, CEO of Co-Diagnostics, commented, "The market for high-throughput, cost-effective COVID-19 tests continues to be strong, and eliminating the costly and time-consuming RNA extraction step allows for even greater speed and economic advantages. We believe the conclusions of this whitepaper speak to the strength, innovation, and flexibility of our CoPrimer platform not just as it relates to creating improved testing technology for COVID-19, but also additional possibilities to implement CoPrimers in various other diagnostic applications. Our next steps include incorporating extraction-free saliva direct tests into the Company product offerings, including those for COVID-19, so they can be available to our customer base world-wide."
Release of the Company whitepaper follows recent news that Clinical Reference Laboratory (CRL) is now selling its CRL Rapid Response saliva-based COVID-19 RT-PCR test directly to consumers. The CRL announcement states that the test uses CoPrimer probes and primers developed by Co-Diagnostics with high degrees of sensitivity and specificity, and a simple saliva collection device that can be administered in virtually any setting, with results in typically 24 hours that are delivered via a secure online computer or mobile device platform.
Mr. Egan continued, "CRL has been an invaluable customer and partner in providing high-quality molecular diagnostic COVID-19 tests to individuals and organizations across the country, helping to facilitate the safe reopening of schools, business, and other organizations. We are pleased that its CRL Rapid Response test will now be even more widely available to consumers online."
Co-Diagnostics' existing CE-marked and FDA EUA Logix Smart COVID-19 test is available to all clinical laboratories certified under Clinical Laboratory Improvement Amendments (CLIA), and is authorized to be used for the diagnosis of SARS-CoV-2, the virus that causes COVID-19, in the US and many other countries.
https://news.codiagnostics.com/2020-11-11-Co-Diagnostics-Inc-CoPrimers-TM-Shown-to-be-Effective-in-COVID-19-Saliva-PCR-Tests-Without-Sample-Extraction
Opti
Hebrews 11:6 And without faith it is impossible to please Him, for he who comes to God must believe that He is and that He is a rewarder of those who seek Him.
Recent CODX News
- Co-Diagnostics, Inc. Completes Updated Clade Ib Analysis of 2-Gene Mpox RUO Test • PR Newswire (US) • 09/05/2024 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/30/2024 08:30:22 PM
- Co-Diagnostics, Inc. to Present at 16th Next Generation Dx Summit in Washington, D.C. • PR Newswire (US) • 08/15/2024 01:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2024 08:06:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2024 08:01:23 PM
- Co-Diagnostics, Inc. Reports Second Quarter 2024 Financial Results • PR Newswire (US) • 08/08/2024 08:01:00 PM
- Co-Diagnostics, Inc. to Host Booth and Discuss Advancing POC/OTC Diagnostics at ADLM 2024 in Chicago • PR Newswire (US) • 07/29/2024 01:30:00 PM
- Co-Diagnostics, Inc. Announces Second Quarter 2024 Earnings Release Date and Webcast • PR Newswire (US) • 07/25/2024 01:30:00 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 07/16/2024 08:15:11 PM
- Co-Diagnostics, Inc. Expands Vector Control Customer Base to 25 Customers across 15 U.S. States • PR Newswire (US) • 07/02/2024 01:30:00 PM
- Co-Diagnostics, Inc. to Participate at FIME 2024 in Miami Beach, June 19-21 • PR Newswire (US) • 06/18/2024 05:30:00 PM
- Co-Diagnostics, Inc. Submits First FDA 510(k) Application for Co-Dx PCR Pro Platform • PR Newswire (US) • 06/14/2024 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/14/2024 11:35:43 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/28/2024 08:01:51 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/28/2024 08:01:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2024 08:05:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 08:01:37 PM
- Co-Diagnostics, Inc. Reports First Quarter 2024 Financial Results • PR Newswire (US) • 05/09/2024 08:01:00 PM
- Co-Diagnostics, Inc. Announces First Quarter 2024 Earnings Release Date and Webcast • PR Newswire (US) • 04/25/2024 01:30:00 PM
- Co-Diagnostics, Inc. to Host Booth and Deliver Presentation at APRC 2024 in Taiwan • PR Newswire (US) • 04/24/2024 01:30:00 PM
- Co-Diagnostics, Inc. Inaugurates New Manufacturing Facility in Utah with Ribbon Cutting Event • PR Newswire (US) • 04/12/2024 01:30:00 PM
- Co-Diagnostics, Inc. Appoints New President and Other C-Level Positions • PR Newswire (US) • 04/04/2024 01:30:00 PM
- Co-Diagnostics, Inc. CEO Delivers Manufacturing and Commercialization Update in Conference Keynote Address • PR Newswire (US) • 03/21/2024 01:30:00 PM
- Co-Diagnostics, Inc. CEO to Deliver Keynote Address at MarketsandMarkets 2024 in London, England • PR Newswire (US) • 03/18/2024 01:30:00 PM
- Co-Diagnostics, Inc. Reports Full Year 2023 Financial Results • PR Newswire (US) • 03/14/2024 08:01:00 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM